Literature DB >> 26598490

New insights into acquired temozolomide resistance in glioblastoma?

Caroline Happold1, Michael Weller2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26598490     DOI： 10.1093/brain/awv301

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  3 in total

1.  Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).

Authors:  Wendy Ha; Hatice Sevim-Nalkiran; Ashraf M Zaman; Kazuko Matsuda; Mustafa Khasraw; Anna K Nowak; Liping Chung; Robert C Baxter; Kerrie L McDonald
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

2.  The PI3K Inhibitor XH30 Enhances Response to Temozolomide in Drug-Resistant Glioblastoma via the Noncanonical Hedgehog Signaling Pathway.

Authors:  Ming Ji; Zhihui Zhang; Songwen Lin; Chunyang Wang; Jing Jin; Nina Xue; Heng Xu; Xiaoguang Chen
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

3.  XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair.

Authors:  Weimin Dai; An Wu; Yunping Li; Guofeng Yu; Xinjiang Yan
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.